Oncology PracticeBiomarker unreliability scratches trial of customized chemotherapyMarch 24, 2014Lung Cancer
Oncology PracticeThe push for smaller, smarter cancer trialsMarch 17, 2014Breast CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung Cancer
Oncology PracticeHormone therapy predicted improved lung cancer survival in womenMarch 4, 2014Lung Cancer
Oncology PracticePrior resection poses certain risks in lung transplantationFebruary 26, 2014Lung Cancer
Oncology PracticeMeaningful use criteria bolster lung cancer screening programFebruary 25, 2014Lung CancerPractice ManagementBusiness of Medicine
Oncology PracticeCompounds in exhaled breath could improve high-risk lung cancer screeningFebruary 10, 2014Lung Cancer
Oncology PracticeLung cancer screening strategy a work in progressFebruary 5, 2014Lung CancerPreventive Care
The Journal of Community and Supportive OncologySynthetic lethality: beating cancer at its own gameFebruary 4, 2014Breast CancerGynecologic CancerLung Cancer
The Journal of Community and Supportive OncologyAfatinib in metastatic NSCLC with mutationsFebruary 4, 2014Lung Cancer
The Journal of Community and Supportive OncologyUnderstanding the experience of living with non–small-cell lung cancer (NSCLC): a qualitative studyFebruary 4, 2014Lung CancerPatient & Survivor Care
Oncology PracticeAnti-PD-L1 therapy yielded durable responses in early NSCLC trialsFebruary 3, 2014Lung Cancer
